stock decline

Navan faces class action lawsuit alleging failure to disclose 39% surge in marketing costs to $95M in Q3 2025 during October IPO, with lead plaintiff applications due April 24, 2026.

Pomerantz Law Firm investigates $ARQ for alleged securities fraud following March earnings miss and GAC production pause announcement.

Pomerantz LLP investigates $SNAP over disappointing Q2 results, weak guidance, and child safety lawsuit, as stock plunges 26.9%.

Grocery Outlet faces 28% stock plunge, $110M impairment charge, and class action lawsuit following March earnings miss and 36-store closures.

Portnoy Law Firm files class action against $IT on behalf of investors, alleging false statements about contract value growth and consulting revenue amid massive stock declines.

Portnoy Law Firm launches class action against BellRing Brands for allegedly mischaracterizing inventory stockpiling as organic demand, triggering 19-33% stock declines.

Class action lawsuit filed against Gartner for allegedly misrepresenting contract value growth and consulting revenue while downplaying economic risks. Stock fell 27% in August 2025, then 21% in February 2026.

Class action lawsuit filed against $ENPH alleging false statements on inventory management. Stock fell 15% after Q3 2025 disappointment. Lead plaintiffs sought.

Aldeyra Therapeutics ($ALDX) shares crashed 65% following FDA rejection of reproxalap for dry eye disease. Law firm Block & Leviton investigates potential securities fraud.

Class action lawsuit filed against $SLNO over alleged securities fraud tied to DCCR safety concerns, patient death, and disappointing Q3 results that triggered sharp stock declines.

Camping World faces class action securities fraud lawsuit over false inventory management claims. Shareholders who lost money between April-February 2025-2026 can file claims by May 11, 2026.

Beyond Meat ($BYND) shares fell 8.66% after announcing delayed annual report filing due to inventory review. Q4 revenue hit $61M; full-year 2025 projected at $275M.

Tesla shares tumble 20% into bear market as prediction markets forecast Q1 deliveries at 340,000 units—lowest since mid-2022—risking analyst downgrades.

Blackstone, Brookfield, and KKR have fallen 22-43.5% amid private credit concerns, but some see undervalued buying opportunities in these alternative asset titans.

Johnson Fistel investigates Aldeyra Therapeutics after FDA rejects lead drug reproxalap. Stock tumbles over 70% on March 17, 2026 announcement.

Alcon terminates $14/share LENSAR merger after FTC regulatory delays. LENSAR stock crashes 25.44% to 52-week low of $7.65, destroying shareholder value.

Law firm Kirby McInerney investigates $TREX for potential securities violations following Q3 disappointment, 26% sequential sales decline, and slashed 2025 guidance.

ODDITY Tech ($ODD) shares crashed 49% after disclosing 30% Q1 revenue decline tied to advertising partner algorithm change. Securities class action filed.

CRMT shares fell 18.2% after reporting Q1 loss of 69 cents per share versus 15 cents prior year, prompting securities investigation.

Class action lawsuit filed against $ORCL alleging misleading statements about AI infrastructure strategy and capital expenditures between June-December 2025.